CIK: 1283290 - Address: C/O Boundless Bio, Inc., 9880 Campus Point Drive, Suite 120, San Diego, CA 92121
36 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg
P%ret114352316101312
P%wins757510050505067
S%ret111132-7-13-27-34-13
S%wins273673919110070

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y
12/6/23 19:41
12/5/23
ERASErasca, Inc.DEHealthDrugPharmaceutical PreparationsLim Jonathan ECADOTCB,CEOP.m1,6961.7001,000332,356I
10/10/23 08:00
10/5/23
ERASErasca, Inc.DEHealthDrugPharmaceutical PreparationsLim Jonathan ECADOTCB,CEOP2,0262.0301,000331,356I
6/8/23 20:54
6/8/23
ERASErasca, Inc.DEHealthDrugPharmaceutical PreparationsLim Jonathan ECADOTCB,CEOP2752.750100030,296I
3/28/23 21:24
3/28/23
ERASErasca, Inc.DEHealthDrugPharmaceutical PreparationsLim Jonathan ECADOTCB,CEOP2842.840100030,196I
1/10/23 16:46
1/10/23
ERASErasca, Inc.DEHealthDrugPharmaceutical PreparationsLim Jonathan ECADOTCB,CEOP2313.86060032,156I
12/15/22 11:53
12/14/22
ERASErasca, Inc.DEHealthDrugPharmaceutical PreparationsLim Jonathan ECADOTCB,CEOP2004.99040032,096I
3/10/17 20:05
2/13/17
RXDXIgnyta, Inc.HealthDrugPharmaceutical PreparationsLim Jonathan ECADOTP,CEO,DiM.d40.60004703,480D1723534174-80-400-6
4/13/16 19:12
4/11/16
RXDXIgnyta, Inc.DEHealthDrugPharmaceutical PreparationsLim Jonathan ECADOTP,CEO,DiM.d160.600022613,473D24-24-23-2810281414-1-23-27-24
3/21/16 12:46
3/17/16
RXDXIgnyta, Inc.DEHealthDrugPharmaceutical PreparationsLim Jonathan ECADOTP,CEO,DiP1375.5122513,447I-45-37-67-55-39-14-23-112945-6962
8/21/15 16:49
8/19/15
RXDXIgnyta, Inc.DEHealthDrugPharmaceutical PreparationsLim Jonathan ECADOTP,CEO,DiP.m10912.903803,350I617133-21-12-12-1108346-44-54
3/24/15 17:14
3/20/15
RXDXIgnyta, Inc.DEHealthDrugPharmaceutical PreparationsLim Jonathan ECADOTP,CEO,DiP1809.0112013,342D-1027382920232-1367781-35
8/19/14 21:00
8/15/14
RXDXIgnyta, Inc.DEHealthDrugPharmaceutical PreparationsLim Jonathan ECADOTP,CEO,DiP387.600503,322D-183-19-8-400-16-12-779
1/14/10 19:10
1/12/10
HALOHalozyme Therapeutics IncDEHealthBioPrdBiological Products, (No DiagLim Jonathan ECADOCEOM.d120.39002304710D-103-7-205-2-2-1-262471731
3/24/08 18:20
3/20/08
HALOHalozyme Therapeutics IncDEHealthBioPrdBiological Products, (No DiagLim Jonathan ECADOP,CEOS-1,5156.063-250-27680D106-24-280191923530-6-13-914-33
3/21/08 16:30
3/19/08
HALOHalozyme Therapeutics IncDEHealthBioPrdBiological Products, (No DiagLim Jonathan ECADOP,CEOM.d900.3900323033930D106-24-280191923530-6-13-914-33
12/4/07 16:26
11/30/07
HALOHalozyme Therapeutics IncNVHealthBioPrdBiological Products, (No DiagLim Jonathan ECADOP,CEOM.d80.39004203700D317161-30-24-17-20-75-2-9-24-23-55
12/4/07 16:26
11/30/07
HALOHalozyme Therapeutics IncNVHealthBioPrdBiological Products, (No DiagLim Jonathan ECADOP,CEOS.d-1658.244-20-3700D317161-30-24-17-20-75-2-9-24-23-55
11/2/07 16:25
10/31/07
HALOHalozyme Therapeutics IncNVHealthBioPrdBiological Products, (No DiagLim Jonathan ECADOP,CEOM.d100.39002254700D392213-1413-3-4-4-51-1-17-31-44-48
11/2/07 16:25
10/31/07
HALOHalozyme Therapeutics IncNVHealthBioPrdBiological Products, (No DiagLim Jonathan ECADOP,CEOS.d-2269.032-25-3700D392213-1413-3-4-4-51-1-17-31-44-48
10/16/07 20:31
10/16/07
HALOHalozyme Therapeutics IncNVHealthBioPrdBiological Products, (No DiagLim Jonathan ECADOP,CEOM.d120.44963274700D3712320-8-10051-1-1-14-28-35-44
10/2/07 16:03
9/28/07
HALOHalozyme Therapeutics IncNVHealthBioPrdBiological Products, (No DiagLim Jonathan ECADOP,CEOM.d100.39005254673D34425910-760-3-1-4-23-20-30-17
10/2/07 16:03
9/28/07
HALOHalozyme Therapeutics IncNVHealthBioPrdBiological Products, (No DiagLim Jonathan ECADOP,CEOS.d-2208.785-25-4673D34425910-760-3-1-4-23-20-30-17
8/31/07 20:11
8/31/07
HALOHalozyme Therapeutics IncNVHealthBioPrdBiological Products, (No DiagLim Jonathan ECADOP,CEOS-1138.822-13-2673D3172113-20-110-1-21332-8-42-12
8/31/07 20:07
8/31/07
HALOHalozyme Therapeutics IncNVHealthBioPrdBiological Products, (No DiagLim Jonathan ECADOP,CEOM.d100.39002254686D3172113-20-110-1-21332-8-42-12
8/31/07 20:07
8/31/07
HALOHalozyme Therapeutics IncNVHealthBioPrdBiological Products, (No DiagLim Jonathan ECADOP,CEOS.d-1058.572-12-2686D3172113-20-110-1-21332-8-42-12
8/2/07 16:16
7/31/07
HALOHalozyme Therapeutics IncNVHealthBioPrdBiological Products, (No DiagLim Jonathan ECADOP,CEOM.d80.39003203673D3712426-22-20-20-14-5-610011-35-4
8/2/07 16:16
7/31/07
HALOHalozyme Therapeutics IncNVHealthBioPrdBiological Products, (No DiagLim Jonathan ECADOP,CEOS.d-1648.203-20-3673D3712426-22-20-20-14-5-610011-35-4
7/2/07 10:39
6/29/07
HALOHalozyme Therapeutics IncNVHealthBioPrdBiological Products, (No DiagLim Jonathan ECADOP,CEOS-799.596-8-1673D4162691215-12-10-8257-13-6-23-42
7/2/07 10:38
6/29/07
HALOHalozyme Therapeutics IncNVHealthBioPrdBiological Products, (No DiagLim Jonathan ECADOP,CEOM.d100.39006254682D4162691215-12-10-8257-13-6-23-42
7/2/07 10:38
6/29/07
HALOHalozyme Therapeutics IncNVHealthBioPrdBiological Products, (No DiagLim Jonathan ECADOP,CEOS.d-1589.436-17-2682D4162691215-12-10-8257-13-6-23-42
6/26/07 17:57
6/25/07
HALOHalozyme Therapeutics IncNVHealthBioPrdBiological Products, (No DiagLim Jonathan ECADOP,CEOM.d380.390069617673D402287227-13-17-11-102710-22-40
6/1/07 18:24
5/31/07
HALOHalozyme Therapeutics IncNVHealthBioPrdBiological Products, (No DiagLim Jonathan ECADOP,CEOS-6210.593-6-1577D4003172602512-2-3-111-12-19-23-52
6/1/07 18:21
5/31/07
HALOHalozyme Therapeutics IncNVHealthBioPrdBiological Products, (No DiagLim Jonathan ECADOP,CEOM.d50.39003132583D4003172602512-2-3-111-12-19-23-52
6/1/07 18:21
5/31/07
HALOHalozyme Therapeutics IncNVHealthBioPrdBiological Products, (No DiagLim Jonathan ECADOP,CEOS.d-19810.353-19-3583D4003172602512-2-3-111-12-19-23-52
3/24/05 14:48
3/24/05
HTIHalozyme Therapeutics IncNVHealthBioPrdBiological Products, (No DiagLim Jonathan ECADOP,C. E. M.d390.3900010020589D
8/18/04 19:46
8/18/04
HZYMHalozyme Therapeutics IncNVHealthBioPrdBiological Products, (No DiagLim Jonathan ECADOP,CEOP81.61051489D

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact